Search research articles
Contact Us
Filters
Showing results (161-170 of 268) with videos related to
Page
of 27
Sort By:
Psychopharmacology
|
January 1, 1982
REM sleep suppression induced by selective monoamine oxidase inhibitors
R M Cohen, D Pickar, D Garnett, et al.
The American Journal of Psychiatry
|
December 1, 1986
Serum antibodies to Epstein-Barr virus in patients with major depressive disorder
J D Amsterdam, W Henle, A Winokur, et al.
Psychoneuroendocrinology
|
February 8, 2003
Neuroendocrine and behavioral effects of high-dose anabolic steroid administration in male normal volunteers
R C Daly, T-P Su, P J Schmidt, et al.
The American Journal of Psychiatry
|
October 13, 1999
Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia
C M Adler, A K Malhotra, I Elman, et al.
The American Journal of Psychiatry
|
December 8, 1998
Cognitive substrates of thought disorder, I: the semantic system
T E Goldberg, M S Aloia, M L Gourovitch, et al.
The American Journal of Psychiatry
|
August 1, 1989
Alprazolam augmentation of neuroleptics in schizophrenia
O M Wolkowitz, A Breier, A Doran, et al.
Psychopharmacology
|
January 1, 1985
Tyramine pressor sensitivity changes during deprenyl treatment
T Sunderland, E A Mueller, R M Cohen, et al.
Biological Psychiatry
|
June 1, 1984
High dose naloxone in depression
M R Cohen, R M Cohen, D Pickar, et al.
Biological Psychiatry
|
November 15, 1992
Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans
A Breier, O Davis, R Buchanan, et al.
Psychiatry Research
|
August 1, 1981
Effect of carbamazepine on CSF opioid activity; relationship to antidepressant response
R M Post, D Pickar, D Naber, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 268) with videos related to
Sort By:
Page
of 27
Psychopharmacology
|
January 1, 1982
REM sleep suppression induced by selective monoamine oxidase inhibitors
R M Cohen, D Pickar, D Garnett, et al.
The American Journal of Psychiatry
|
December 1, 1986
Serum antibodies to Epstein-Barr virus in patients with major depressive disorder
J D Amsterdam, W Henle, A Winokur, et al.
Psychoneuroendocrinology
|
February 8, 2003
Neuroendocrine and behavioral effects of high-dose anabolic steroid administration in male normal volunteers
R C Daly, T-P Su, P J Schmidt, et al.
The American Journal of Psychiatry
|
October 13, 1999
Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia
C M Adler, A K Malhotra, I Elman, et al.
The American Journal of Psychiatry
|
December 8, 1998
Cognitive substrates of thought disorder, I: the semantic system
T E Goldberg, M S Aloia, M L Gourovitch, et al.
The American Journal of Psychiatry
|
August 1, 1989
Alprazolam augmentation of neuroleptics in schizophrenia
O M Wolkowitz, A Breier, A Doran, et al.
Psychopharmacology
|
January 1, 1985
Tyramine pressor sensitivity changes during deprenyl treatment
T Sunderland, E A Mueller, R M Cohen, et al.
Biological Psychiatry
|
June 1, 1984
High dose naloxone in depression
M R Cohen, R M Cohen, D Pickar, et al.
Biological Psychiatry
|
November 15, 1992
Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans
A Breier, O Davis, R Buchanan, et al.
Psychiatry Research
|
August 1, 1981
Effect of carbamazepine on CSF opioid activity; relationship to antidepressant response
R M Post, D Pickar, D Naber, et al.
Page
of 27